Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,426 | -$32,543 | -$33,641 | -$23,054 |
| Dep. & Amort. | $210 | $194 | $180 | $165 |
| Deferred Tax | $576 | $576 | $576 | -$167 |
| Stock-Based Comp. | $11,840 | $6,617 | $3,906 | $1,455 |
| Change in WC | -$1,685 | -$4,006 | $240 | -$2,717 |
| Other Non-Cash | $284 | $102 | $378 | $68 |
| Operating Cash Flow | -$28,201 | -$29,060 | -$28,361 | -$24,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$40,007 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,000 | $0 | $0 | $0 |
| Investing Cash Flow | -$5,000 | $0 | $0 | -$40,007 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$173 |
| Stock Issued | $13,804 | $13,798 | $0 | $89,431 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,831 | $31 | $0 | $31,213 |
| Financing Cash Flow | $9,972 | $13,829 | $0 | $120,471 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23,229 | -$15,231 | -$28,361 | $56,213 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,481 | $41,712 | $70,073 | $13,860 |
| End Cash | $3,252 | $26,481 | $41,712 | $70,073 |
| Free Cash Flow | -$28,201 | -$29,060 | -$28,361 | -$64,257 |